Revvity announced it has entered a definitive agreement to acquire ACD/Labs, a long-established provider of analytical and chemical intelligence software. The deal expands Revvity Signals’ capabilities across the scientific workflow, with new tools for characterizing molecules, predicting molecular properties, managing analytical data, and supporting process chemistry from discovery through scale-up.
For laboratory leaders, the acquisition underscores a broader industry shift toward scientific software integration—bringing disparate tools into unified platforms that support consistent data structures, faster interpretation, and improved decision-making.
Expanding capabilities across analytical chemistry and molecular design
ACD/Labs is best known for its suite of analytical and chemistry-centric applications, including the Spectrus Platform for spectral analysis, Percepta for AI-driven property prediction, and Luminata for pharmaceutical manufacturing and controls decision support. These tools are widely used in pharmaceutical, chemical, and materials science labs to support purity assessments, impurity tracking, method development, and complex data review.
Revvity Signals plans to integrate these capabilities into its cloud-based informatics ecosystem. According to Kevin Willoe, president of Revvity Signals Software, “By integrating ACD/Labs’ technologies into the Revvity Signals platform, we’re giving our customers across pharmaceuticals and material sciences a truly unified SaaS environment—one that connects molecular design, analytical science, and manufacturing quality control within a single, end-to-end solution.”
ACD/Labs leaders emphasized continuity and expanded reach. “For more than three decades, our scientists, informaticians, and software developers have been recognized as leaders in analytical and chemical intelligence,” said Daria Thorp, president and CEO. “Together, we will expand the reach of our technology and deliver unified, end-to-end solutions that empower customers with deeper insight and greater scientific continuity.”
What a unified informatics platform means for lab operations
For lab managers overseeing digital transformation, this consolidation offers potential advantages:
- Streamlined data management: Spectral, chromatographic, structural, and batch data stored in more cohesive environments
- Reduced software fragmentation: One vendor providing capabilities traditionally spread across multiple platforms
- Improved analytical review workflows: Faster interpretation of MS, NMR, LC, and other instrument data
- Enhanced manufacturing continuity: Better linkage between discovery, development, and process chemistry environments
- AI-ready data models: More consistent datasets supporting predictive tools such as ADMET modeling and impurity forecasting
These trends reflect increasing pressure on labs to handle larger datasets, ensure data integrity, and accelerate decision-making across cross-functional research and manufacturing teams.
Key considerations for lab managers evaluating scientific software integration
While the acquisition brings opportunities, lab leaders will want to evaluate potential impacts over the next year:
- Licensing and support changes: Existing ACD/Labs users may see updates to service structures, integration pathways, and roadmap timing
- Validation and compliance: Any transition to unified cloud-based systems may require updates to SOPs, IT policies, and quality documentation
- Staff training: Integrating new tools into existing digital ecosystems will require cross-training for chemists, analysts, and QA personnel
- Data migration: Labs with extensive spectral or chromatographic archives should assess migration options and long-term storage compatibility
These considerations will help ensure a smooth transition as the two platforms converge.
Preparing for next-generation informatics ecosystems
The acquisition highlights a growing movement toward end-to-end lab informatics ecosystems, where analytical chemistry, molecular design, and manufacturing operations sit within a single digital environment. For lab managers, staying informed about these consolidations is essential for long-term planning—particularly when evaluating software investments, supporting data integrity, and managing the lifecycle of analytical data across research and development.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
